NRO Neurones SA

NEURONES: Net profit (group share) up 11.5% in 2023

NEURONES: Net profit (group share) up 11.5% in 2023

PRESS INFORMATION

Heading: 2023 annual results        Nanterre, March 6, 2024 (after trading)

Net profit (group share) up 11.5% in 2023

Financial statements at December 31 (1)20222023
Revenues665.4741.2
Business operating profit (2)77 (11.6%)81.5 (11%)
Operating profit72.9 (11%)75.9 (10.2%)
Financial profit04.9
Tax on earnings(21.1)(22.2)
Net profit51.8 (7.8%)58.6 (7.9%)
- of which, group share44.349.4
Free cash flow (3)37.651.6
Cash and cash equivalents (net of financial debt) (4)271.8290.4
Staff at year-end6,4066,749

(1)        In millions of euros, 2023 financial statements approved by the Board of Directors on March 6, 2024.

(2)        Before cost of bonus shares.

(3)        Cash flow from operational activities, plus financial profit and less net industrial investments.

(4)        Excluding IFRS16 lease liabilities.

Achievements

NEURONES once again achieved double-digit growth in 2023 (+11.4%, of which +11.1% organic), while net income stood at 7.9% of revenues (7.8% in 2022).

Free cash flow rose sharply, thanks to a virtually stable working capital requirement, even after significant investment in the new SecNumCloud sovereign and secure cloud platform. Capex amounted to €17.9 million (previous year: €10.6 million).

Cash and cash equivalents at the end of the year stood at €290.4 million (€12 per share).

Outlook

As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues (on May 15, after trading). Driven by solid underlying trends (cloud and digital), NEURONES is well positioned to achieve another year of profitable growth.

At the Shareholders' Meeting on June 6, the Board will suggest paying a dividend of €1.2 per share for 2023.

About NEURONES

With over 6,800 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – SRD (deferred settlement) mid-caps



Press Relations:

O'Connection

Valérie Hackenheimer

Tel.: +33 (0)6 12 80 35 20









NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37



Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37



Attachment



EN
06/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

NEURONES: Organic growth up 5.3% in 2nd quarter 2025 PRESS INFORMATION        Nanterre, August 6, 2025 (after trading)Heading: 1st half 2025 revenues Organic growth up 5.3% in 2nd quarter 2025 Revenues (millions of euros)20242025Growthof which organicQ1204.9214.1+ 4.5%+ 3.9%Q2197.5210.2+ 6.4%+ 5.3%Total H1 revenues402.4424.3+ 5.4%+ 4.6% Achievements Organic growth of 5.3% in the second quarter was achieved in a more challenging economic environment. The most notable growth was in Data, Digital projects, market finance, ITSM (Service Now) solutions, and Business Process Management, with t...

 PRESS RELEASE

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025 INFORMATION PRESSE        Nanterre, le 6 août 2025 (après Bourse)Rubrique : C.A. 1er semestre 2025 + 5,3% de croissance organique au 2e trimestre 2025 C.A. (en millions d’euros)20242025Croissancedont organique1er trimestre204,9214,1+ 4,5%+ 3,9%2e trimestre197,5210,2+ 6,4%+ 5,3%Total 1er semestre402,4424,3+ 5,4%+ 4,6% Réalisations A 5,3%, la croissance organique du deuxième trimestre a été réalisée dans des conditions économiques plus tendues. Les progressions les plus notables concernent la Data, les projets Digitaux, la fina...

 PRESS RELEASE

NEURONES : Descriptif du programme de rachat d'actions

NEURONES : Descriptif du programme de rachat d'actions INFORMATION PRESSERubrique : Rachat d’actions                                         Nanterre, le jeudi 5 juin 2025 (après Bourse) DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS L’Assemblée Générale des actionnaires du 5 juin 2025 a renouvelé l’autorisation consentie au Conseil d’administration, pour une durée de 18 mois, de procéder à l’achat des propres actions de la société. Etabli en application de l’article 241-2 et suivants du Règlement général de l’AMF, le présent descriptif précise les modalités et les objectifs du programme d...

 PRESS RELEASE

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025 PRESS INFORMATIONHeading: 1st quarter revenues 2025        Nanterre, May 7, 2025 (after trading) 3.9% increase in organic growth in the 1st quarter of 2025 (in millions of euros)Q1 2024Q1 2025Growthof which organicRevenues204.9214.1+ 4.5%+ 3.9% Achievements Driven by its cloud, digital and data activities, the Group's organic growth increased by 3.9% over the first three months of the year. Operating profit (*) totaled 8.2% of revenues. The increase in taxation (the fixed social security charge on bonus shares rose...

 PRESS RELEASE

NEURONES : + 3,9% de croissance organique au 1er trimestre 2025

NEURONES : + 3,9% de croissance organique au 1er trimestre 2025 INFORMATION PRESSERubrique : C.A. 1er trimestre 2025        Nanterre, le 7 mai 2025 (après Bourse) + 3,9% de croissance organique au 1er trimestre 2025 (en millions d’euros)T1 2024T1 2025Croissancedont organiqueChiffre d’affaires204,9214,1+ 4,5%+ 3,9% Réalisations Soutenue par le cloud, le digital et la data, la croissance organique du groupe s’établit à + 3,9% sur les trois premiers mois de l’année. Le résultat opérationnel (*) s’élève à 8,2% du chiffre d’affaires. La fiscalité en hausse (passage de 20 à 30% du forfait soci...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch